Literature DB >> 11023666

gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.

E Tone1, K Kunisada, A Kumanogoh, S Negoro, M Funamoto, T Osugi, T Kishimoto, K Yamauchi-Takihara.   

Abstract

Activation of gp130 transduces a hypertrophic signal in the heart, but it is not clear whether signalling through gp130 is enhanced when gp130 is overexpressed in vivo. We generated gp130 transgenic mice (TG) and examined the activation of signalling pathways downstream of gp130 in the hearts. The tyrosine phosphorylation of gp130 was enhanced, the phosphorylation of STAT3 and ERK (extracellular signal regulated kinase) 1/2 was increased and induction of the beta-myosin heavy chain (MHC) gene was observed in TG hearts without significant phenotypic changes. Intravenous administration of leukaemia inhibitory factor (LIF) induced tyrosine phosphorylation of STAT3 and ERK 1/2 and expression of c-fos and beta-MHC mRNAs in wild-type littermates' (WT) hearts. However, enhancement of STAT3 and ERK 1/2 phosphorylation or augmented mRNA expressions was not observed in TG hearts after LIF stimulation. Next, STAT-induced STAT inhibitor (SSI) mRNA expression was examined. The expression of SSI-1, SSI-2, and SSI-3 mRNAs was significantly augmented in TG hearts after LIF stimulation. These results indicate that overexpressed gp130 does not always enhance downstream signals in the hearts and suggest that the SSI family plays a role in the regulation of the gp130-dependent signalling pathway in the hearts. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023666     DOI: 10.1006/cyto.2000.0751

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination.

Authors:  Ben Emery; Holly S Cate; Mark Marriott; Tobias Merson; Michele D Binder; Cameron Snell; Pik Ying Soo; Simon Murray; Ben Croker; Jian-Guo Zhang; Warren S Alexander; Helen Cooper; Helmut Butzkueven; Trevor J Kilpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

2.  Increased expression of IL-6 and LIF in the hypertrophied left ventricle of TGR(mRen2)27 and SHR rats.

Authors:  Mazen Kurdi; Jacques Randon; Catherine Cerutti; Giampiero Bricca
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

3.  Network-based predictions of in vivo cardiac hypertrophy.

Authors:  Deborah U Frank; Matthew D Sutcliffe; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2018-07-17       Impact factor: 5.000

4.  IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart.

Authors:  Indroneal Banerjee; John W Fuseler; Arti R Intwala; Troy A Baudino
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

5.  Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age.

Authors:  Jörg J Jacoby; April Kalinowski; Mu-Gen Liu; Samuel S-M Zhang; Qian Gao; Gui-Xuan Chai; Lan Ji; Yoshiki Iwamoto; En Li; Michael Schneider; Kerry S Russell; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

Review 6.  LIF and the heart: just another brick in the wall?

Authors:  Fouad A Zouein; Mazen Kurdi; George W Booz
Journal:  Eur Cytokine Netw       Date:  2013-03       Impact factor: 2.737

Review 7.  Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects.

Authors:  P Fischer; D Hilfiker-Kleiner
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.